Major GeneDx Shareholder Strengthens Position: Director Gets Fresh Equity Grant
Rhea-AI Filing Summary
Insider Trading Activity Report: Eli Casdin, Director and 10% owner of GeneDx Holdings (WGS), reported multiple transactions on June 18, 2025. The transactions involved Restricted Stock Units (RSUs) and Class A Common Stock:
- Acquired 3,576 new RSUs that vest at the earlier of next annual meeting or first grant anniversary
- Converted 12,924 RSUs into Class A Common Stock at $0 exercise price
- Currently holds beneficial ownership of: - 20,518 shares directly - 3,507,164 shares through Casdin Partners Master Fund - 19,247 shares through Casdin Partners GP - 333,144 shares through CMLS Holdings
The filing indicates significant insider ownership through various investment vehicles, with Casdin maintaining substantial control through multiple entities where he serves in management positions. The transaction was reported within the required timeframe through an attorney-in-fact.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 12,924 shares
Net Buy
6 txns
Insider
Casdin Eli
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 3,576 | $0.00 | $0.00 |
| Exercise | Restricted Stock Unit | 12,924 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 12,924 | $0.00 | $0.00 |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 3,576 shares (Direct);
Class A Common Stock — 20,518 shares (Direct);
Class A Common Stock — 3,507,164 shares (Indirect, See Casdin Partners Master Fund, LP);
Class A Common Stock — 19,247 shares (Indirect, See Casdin Partners GP, LLC);
Class A Common Stock — 333,144 shares (Indirect, See CMLS Holdings LLC)
Footnotes (5)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- F2. The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.
- F3. The securities are owned directly by the GP, the general partner of Casdin Partners Master Fund, L.P. and may be deemed to be indirectly beneficially owned by Eli Casdin, the managing member of the GP.
- F4. The securities are owned directly by CMLS Holdings LLC ("CMLS Holdings"). The Board of Managers of CMLS Holdings includes Eli Casdin, who, as a member of the Board of Managers of CMLS Holdings, shares voting and investment discretion with respect to the common stock held by CMLS Holdings.
- F5. The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider trading activity occurred at GeneDx Holdings (WGS) in June 2025?
Director and 10% owner Eli Casdin received 3,576 new Restricted Stock Units (RSUs) and had 12,924 RSUs vest into Class A Common Stock on June 18, 2025. The transactions were executed at $0 as RSUs convert to shares for no consideration.
What are the vesting terms for WGS's director RSUs granted in 2025?
The RSUs vest at the earlier of: (a) the date of the next annual meeting of GeneDx's shareholders following the grant date, or (b) the first anniversary of the grant date, subject to the director continuing to provide services through the vesting date.
Who is Eli Casdin in relation to GeneDx Holdings (WGS)?
Eli Casdin serves as both a Director and 10% Owner of GeneDx Holdings (WGS). He is also the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC, and serves on the Board of Managers of CMLS Holdings LLC.